Literature DB >> 10444690

Kinematics of eye movements of cats to broadband acoustic targets.

L C Populin1, T C Yin.   

Abstract

Operant conditioning was used to train cats with their heads immobilized to localize sound by directing their eyes to the location of the sources. The kinematics of those eye movements were studied and compared with eye movements to visual targets at the same locations. The main finding of this study is that eye movements to broadband long-duration acoustic targets have two components: an initial slow phase of variable duration and a fast, normal saccade. The slow component is characterized by a persistent, shallow velocity ramp, while the saccadic component of the response falls on the main sequence computed from eye movements to visual targets. The slow component was shorter before saccades to long-duration stimuli performed under the delayed-saccade task and practically absent before saccades to transient acoustic stimuli. The results suggest that the initial slow component is used by cats to deal with uncertainty associated with the location of long-duration broadband targets and that the input to the saccade integrator(s) is similar under both visual and acoustic conditions.

Entities:  

Mesh:

Year:  1999        PMID: 10444690     DOI: 10.1152/jn.1999.82.2.955

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  3 in total

1.  Gaze shifts to auditory and visual stimuli in cats.

Authors:  Janet L Ruhland; Tom C T Yin; Daniel J Tollin
Journal:  J Assoc Res Otolaryngol       Date:  2013-06-08

2.  Target modality determines eye-head coordination in nonhuman primates: implications for gaze control.

Authors:  Luis C Populin; Abigail Z Rajala
Journal:  J Neurophysiol       Date:  2011-07-27       Impact factor: 2.714

3.  Anesthetics change the excitation/inhibition balance that governs sensory processing in the cat superior colliculus.

Authors:  Luis C Populin
Journal:  J Neurosci       Date:  2005-06-22       Impact factor: 6.167

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.